We are live on ! Find out more
CLOV icon

Clover Health Investments

178 hedge funds and large institutions have $293M invested in Clover Health Investments in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 62 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $27M | Put options by funds: $12.2M

95% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 20

88% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 33

27% more capital invested

Capital invested by funds: $231M → $293M (+$61.4M)

12% more funds holding

Funds holding: 159178 (+19)

2.43% more ownership

Funds ownership: 20.12%22.55% (+2.4%)

Holders
178
Holders Change
+19
Holders Change %
+11.95%
% of All Funds
2.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
39
Increased
62
Reduced
33
Closed
20
Calls
$27M
Puts
$12.2M
Net Calls
+$14.9M
Net Calls Change
+$3.41M
Name Holding Trade Value Shares
Change
Change in
Stake
Balyasny Asset Management
26
Balyasny Asset Management
Illinois
$1.38M +$1.26M +351,241 +405%
JP Morgan Chase
27
JP Morgan Chase
New York
$1.36M +$977K +273,348 +172%
AG
28
Algert Global
California
$1.35M +$1.01M +282,321 +193%
Verition Fund Management
29
Verition Fund Management
Connecticut
$1.12M +$754K +210,852 +145%
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$1.11M +$50.3K +14,068 +4%
Legal & General Group
31
Legal & General Group
United Kingdom
$1.09M +$244K +68,256 +25%
Simplex Trading
32
Simplex Trading
Illinois
$953K +$868K +242,810 +406%
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$919K +$1.04M +291,736 New
CL
34
Choreo LLC
Illinois
$915K
Bank of America
35
Bank of America
North Carolina
$895K -$75.2K -21,040 -7%
GCM
36
Graham Capital Management
Connecticut
$889K +$1.01M +282,264 New
SAM
37
Sectoral Asset Management
Quebec, Canada
$866K +$983K +275,000 New
Osaic Holdings
38
Osaic Holdings
Arizona
$821K +$546K +152,777 +142%
Squarepoint
39
Squarepoint
New York
$789K +$402K +112,608 +82%
Ameriprise
40
Ameriprise
Minnesota
$768K -$38.7K -10,830 -4%
ACM
41
Aster Capital Management
United Arab Emirates
$762K +$5.76K +1,611 +0.7%
Point72 Asset Management
42
Point72 Asset Management
Connecticut
$747K -$83.8K -23,450 -9%
CMF
43
Counterpoint Mutual Funds
California
$735K +$504K +141,148 +153%
SRC
44
Sage Rhino Capital
California
$667K -$36 -10 -0%
GCP
45
GSA Capital Partners
United Kingdom
$661K -$534K -149,477 -42%
ECM
46
ExodusPoint Capital Management
New York
$646K +$732K +204,952 New
GL
47
Graypoint LLC
New York
$632K +$717K +200,617 New
PAS
48
Point72 Asia (Singapore)
Singapore
$592K +$672K +188,003 New
UBS Group
49
UBS Group
Switzerland
$540K +$496K +138,772 +426%
TCWA
50
Turtle Creek Wealth Advisors
Texas
$536K

CLOV Hedge Fund Activity: Q4 2024 in Review

178 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q4 2024, worth a combined $293M — up 27% from $231M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new CLOV positions and 20 closed out — a net gain of 19 holders — while 62 added to existing stakes and 33 trimmed.

The largest buyer was Marshall Wace, adding an estimated $8.44M. The largest seller was Renaissance Technologies, cutting an estimated $5.05M.

  • 178 institutional investors held Clover Health Investments (CLOV) as of Q4 2024, up from 159 in Q3 2024.
  • Funds reported $293M of Clover Health Investments stock for Q4 2024, up 27% quarter-over-quarter.
  • 39 funds opened new Clover Health Investments positions in Q4 2024 and 20 closed out, a net change of +19 holders.
  • The largest Clover Health Investments buyer in Q4 2024 was Marshall Wace, an estimated $8.44M added.
  • The largest Clover Health Investments seller in Q4 2024 was Renaissance Technologies, an estimated $5.05M sold.

Based on aggregated 13F filings for Q4 2024.